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We observe that a pathogen introduced into a population containing individuals with acquired immunity can result in an
epidemic longer in duration and/or larger in size than if the pathogen were introduced into a naive population. We call this
phenomenon ‘‘epidemic enhancement,’’ and use simple dynamical models to show that it is a realistic scenario within the
parameter ranges of many common infectious diseases. This finding implies that repeated pathogen introduction or
intermediate levels of vaccine coverage can lead to pathogen persistence in populations where extinction would otherwise be
expected.
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INTRODUCTION
The dynamics of pathogen introduction into a naı ¨ve, or
completely susceptible, host population have been thoroughly
described in the literature and are well understood from both
theoretical and empirical perspectives [1,2,3]. Emerging infectious
diseases are generally considered within this framework [4,5];
however, the possibility of repeated introductions of a ‘‘novel’’
pathogen into a single host population, or of attempts to pro-
phylactically vaccinate populations considered to be at risk for
pathogen spillover, requires that we consider the dynamics of
infections introduced into pathogen-free populations comprising
both susceptible individuals and those with acquired immunity,
referred to here as ‘‘partially immune’’ populations. A recent
paper by Savill et al. used a detailed stochastic model to show that
introduction of H5N1 avian influenza into vaccinated poultry
populations could promote undetected pathogen persistence,
facilitating ‘‘silent’’ spread to neighboring farms [6]. We use very
simple dynamical models to demonstrate the generality of this
phenomenon.
RESULTS
Differential equation model
Damped or sustained oscillations in the number of infectious
individuals are a common feature of infectious disease dynamics
and are reproduced in even the simplest disease models. For a wide
range of realistic parameters, however, differential equation
models, which are continuous and deterministic, exhibit a behavior
that is generally considered biologically implausible. Although the
epidemic caused by pathogen introduction into the naı ¨ve host
population is self-limiting (that is, after an initial explosion of cases,
the susceptible population is depleted to such an extent that the
epidemic trajectory dips below the point where a single infectious
individual is present in the population), the infection never
completely disappears from the population (0,I,,1) due to the
treatment of individuals as continuous in this type of model.
Instead, the susceptible population is replenished following the
initial epidemic and eventually reaches a level where the effective
reproductive number of the pathogen in the population, Re,i s
greater than one. A new epidemic occurs, which is longer in
duration than the initial epidemic but has a lower epidemic peak.
In this manner, the system eventually reaches an endemic equili-
brium where the pathogen persists (I*.1). The key parameters
which determine whether an infection will exhibit this behavior
are the host population size (N), the basic reproductive number of
the pathogen in the host population (R0), and the ratio (r) of the
duration of infectiousness to the average duration of immunity.
Figure 1 shows the region of (r,R0) parameter space over which the
number of infectives falls below one after an initial epidemic for
a population of 50,000 individuals.
Stochastic model
Although results of the differential equation model are dependent
on the treatment of individuals as continuous entities, analogous
behavior is observed in stochastic systems with discrete individuals
when a pathogen is introduced or reintroduced into a partially
immune population. The presence of immune individuals in the
population results in a lower force of infection upon introduction
or reintroduction of the pathogen. Instead of burning through the
susceptible population and driving itself to extinction as in a naı ¨ve
population, the pathogen produces a smaller epidemic with a less
dramatic depletion of individuals, which may in turn allow the
pathogen to persist. Within the region of parameter space where
this occurs, the level of population immunity present at the time of
introduction will determine whether spillover leads to no epidemic,
a self-limiting epidemic, or long-term persistence. Introduction
into a partially immune population with intermediate levels of
population immunity will often lead to an epidemic of longer
duration and/or higher total number of infectious individuals than
introduction into a naı ¨ve population, a phenomenon which we call
‘‘epidemic enhancement.’’ Figure 1 illustrates that a variety of
common and emerging infectious diseases fall within the region of
parameter space where enhancement is expected. This suggests
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of these diseases to establish in the human population. Stochastic
model results (Figures 2 & 3) suggest that enhancement of
epidemic duration is common throughout this region of para-
meter space, whereas enhancement of epidemic size is only
observed where equilibrium populations of infectious individuals
are sufficient to allow long-term persistence without stochastic
extinction.
DISCUSSION
Epidemic enhancement may have important implications for
emerging infectious diseases, particularly because pathogen
persistence within an isolated population will increase the time
span over which movement of individuals may spread the disease
to new areas and may also decrease the probability that infection
will be detected or diagnosed [6]. Of primary concern is the
possibility that prophylactic vaccination would promote pathogen
persistence in populations with high turnover rates, such as on
domestic livestock and poultry farms, because large-scale vacci-
nation efforts are unlikely to vaccinate frequently enough to
maintain herd immunity within farm populations characterized by
rapid turnover. As discussed by Savill et al., incomplete vaccine
efficacy would lead to similar dynamics [6].
Finally, we must be aware that the same effect can be produced
by repeated introductions of a pathogen into a single population.
Thus, populations which are known to have been infected with
a pathogen of interest must be considered to pose substantial risk
even if they are currently pathogen-free. In 1998, the reintroduc-
tion of Nipah virus onto a previously exposed pig farm appears to
have been responsible for the long-term persistence of the virus,
which eventually led to widespread infection in pigs and people (J.
Pulliam, unpublished results). Although this is the only example
known to us in which enhancement has facilitated the spread of an
infectious agent into human populations, the mathematically
robust nature of this phenomenon suggests that we must take the
possibility of enhancement into account when considering the
prevention and control of emerging diseases.
MATERIALS AND METHODS
Pathogen dynamics in a simple differential equation
SIR model
Model structure The following model is used to explore
the dynamics of pathogen introduction into partially immune
populations:
dS
dt
~lR{bSI
dI
dt
~bSI{cI
dR
dt
~cI{lR
where S is the number of susceptible individuals, I is the number of
infectious individuals, R is the number of recovered (immune)
individuals, c is recovery rate (c=D
21, where D is the average
duration of infection), l is turnover rate of the immune population,
and b is the transmission coefficient. The total population size,
N=S+I+R, remains constant, so only two equations are needed to
describe the entire system. Rescaling time to be in units of the
infectious period (i.e.,t=ct), and recognizing that the basic
reproductive ratio (the number of infectious individuals pro-
duced by a single infectious individual in a naı ¨ve population) is
R0~
bN
c
, gives:
dS
dt
~r N{S{I ðÞ {
R0SI
N
ð1Þ
dI
dt
~
R0SI
N
{I ð2Þ
where r~
l
c
is the rescaled turnover rate. The system has two
equilibria: a trivial disease-free equilibrium (S*=N, I*=0) and an
Figure 1. Deterministic prediction of the parameter ranges where
epidemic enhancement may be observed. The range of parameter
values (grey) for a population size of N=50,000 and the initial condition
(S0,I0)=(N21, 1) which demonstrate the behavior of an initial epidemic
which dies out (there exists t.0 such that It,1) followed by persistence
upon reintroduction (I*.1), depending on the level of population
turnover between pathogen extinction and reintroduction. R0 is the
basic reproductive number of the pathogen in a naı ¨ve host population;
r is the duration of infectiousness relative to the average duration of
immunity. Stars represent parameter values taken from the literature for
a variety of common and emerging infectious diseases. Note that the x-
axis is shown on a log scale. Parameter values used, estimated ranges of
parameter values, and references are given in Table S1.
doi:10.1371/journal.pone.0000165.g001
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N
R0
I ~
rN 1{ 1
R0
  
1zr
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Model assumptions Several key assumptions should be noted:
1. The population is well-mixed, and all individuals in the
population are identical, except with regard to infection status
(e.g., there is no age structure).
2. Transmission is density dependent.
3. Waiting times for all events are exponentially-distributed.
4. Both time and the number of individuals in each class are
continuous variables.
5. There is no mortality due to infection.
6. There is complete overlap between ‘‘infected’’ and ‘‘in-
fectious’’ individuals (i.e., there is no incubation period before
infectivity and there are no latent infections).
7. The duration of infection is sufficiently short that background
mortality in the infectious class can be ignored. Death is explicit
only in the recovered class and dying individuals are immediately
replaced by birth of susceptible individuals, keeping population
size constant (this could also be viewed as an immigration/emigra-
tion process or as loss of immunity in a constant population). This
assumption should be modified when considering diseases with
particularly long infectious periods, such as many STD’s.
Stability of equilibria The endemic equilibrium is stable
whenever R0.1, with damped oscillations observed in the region
where R0.1 and
lz4z
2
l
{
2
l
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
lz1 ðÞ
3
q
vR0vlz4z
2
l
z
2
l
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
lz1 ðÞ
3
q
:
When R0,1, the endemic equilibrium is a saddle point. The
disease-free equilibrium is a stable node when R0,1 and a saddle
point when R0.1.
Stochastic implementation of the SIR model
Although the ODE model is a useful tool for understanding
the dynamics of pathogen introduction, the treatment of
individuals as continuous entities can produce strange results.
This assumption can easily be discarded by developing
a stochastic analogue to the ODE model with discrete
individuals, after [7] (the other assumptions described above
remain).
The stochastic model takes the following form, in which time is
rescaled as above (see Equations 1 & 2):
S, I, R ðÞ ? S{1, Iz1, R ðÞ at rate
R0SI
N
,
S, I, R ðÞ ? S, I{1, Rz1 ðÞ at rate I,
S, I, R ðÞ ? Sz1, I, R{1 ðÞ at rate rR:
Figure 2. Stochastic demonstration of epidemic enhancement in partially immune populations. Each plot is a comparison of the outcome of the
runs starting with a particular immunity level to the 90
th percentile of runs in a naı ¨ve population. Black spaces show where enhancement occurs; that
is, .15% of epidemics in partially immune population are longer (top row) or larger (bottom row) than the 90
th percentile of epidemics in a naı ¨ve
population. Grey spaces show the area where 5–15% of the epidemics in the partially immune population are longer or larger than the 90
th percentile
of epidemics in a naive population (so vaccination has little or no effect in either direction). The simulation was run 500 times for introduction into
a naı ¨ve population for each set of parameter values, and these runs were used to determine the 90
th percentile for epidemic duration and size; the
pathogen was considered to persist if it remained in the population for $300 disease generations. The simulation was then run 500 times for each of
the levels of initial population immunity (25%, 50%, 75%, 90%) in the portion of parameter space for which the pathogen did not persist in the naı ¨ve
population. The total population size is N=50,000.
doi:10.1371/journal.pone.0000165.g002
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The parameters R0 and r were derived from estimates in the
literature. The rescaled turnover rate, r~
l
c
~
D
L
, was calculated
as the ratio of D (the expected duration of the infectious period) to
L (the average duration of immunity), where the parameter values
given were first converted to days. For human diseases producing
lifelong immunity, L was assumed to be 65 years. Table S1 gives
the parameter values used and lists the appropriate references.
SUPPORTING INFORMATION
Table S1 Parameter values and references. Table S1 gives
parameter values used, estimated ranges of parameter values, and
appropriate references.
Figure 3. Enhancement of epidemic duration for diseases in human populations. Epidemic duration in a population of N=50,000 individuals for
a variety of human pathogens as a function of population immunity at introduction. Solid lines show the median duration in disease generations for
1,000 simulation runs at each level of initial population immunity; dashed lines show quartiles. Each pathogen shows some level of enhancement of
epidemic duration with increased immunity except pertussis. Enhancement of epidemic size is not observed for these pathogens for N=50,000.
doi:10.1371/journal.pone.0000165.g003
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